Analyst Expectations for NextGen Healthcare's Future
Portfolio Pulse from Benzinga Insights
NextGen Healthcare (NASDAQ:NXGN) has received mixed analyst ratings in the last quarter, with 1 bullish, 2 somewhat bullish, and 2 indifferent ratings. The average 12-month price target for the company, according to 5 analysts, is $20.2, an increase of 6.32% from the previous average of $19.00.
August 28, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Mixed analyst ratings and an increased price target could lead to volatility in NextGen Healthcare's stock price.
The mixed analyst ratings indicate uncertainty about the company's future performance. The increased price target suggests that analysts see potential for growth, but the range of ratings could lead to volatility in the stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100